122 related articles for article (PubMed ID: 23473945)
21. Morphologic evidence that neurokinin B modulates gonadotropin-releasing hormone secretion via neurokinin 3 receptors in the rat median eminence.
Krajewski SJ; Anderson MJ; Iles-Shih L; Chen KJ; Urbanski HF; Rance NE
J Comp Neurol; 2005 Aug; 489(3):372-86. PubMed ID: 16025449
[TBL] [Abstract][Full Text] [Related]
22. Identification, localization and receptor characterization of novel mammalian substance P-like peptides.
Kurtz MM; Wang R; Clements MK; Cascieri MA; Austin CP; Cunningham BR; Chicchi GG; Liu Q
Gene; 2002 Aug; 296(1-2):205-12. PubMed ID: 12383518
[TBL] [Abstract][Full Text] [Related]
23. Neurokinin 3 receptor-selective agonist, senktide, decreases core temperature in Japanese Black cattle.
Nakamura S; Miwa M; Morita Y; Ohkura S; Yamamura T; Wakabayashi Y; Matsuyama S
Domest Anim Endocrinol; 2021 Jan; 74():106522. PubMed ID: 32841888
[TBL] [Abstract][Full Text] [Related]
24. Targeting neurokinin-3 receptor: a novel anti-angiogenesis strategy for cancer treatment.
Wang T; Chen S; Wang S; Shi L; Wang C; Zhang J; Gao Y; Li G; Qi Y; An X; Chen L
Oncotarget; 2017 Jun; 8(25):40713-40723. PubMed ID: 28489574
[TBL] [Abstract][Full Text] [Related]
25. The third intracellular loop and carboxyl tail of neurokinin 1 and 3 receptors determine interactions with beta-arrestins.
Schmidlin F; Roosterman D; Bunnett NW
Am J Physiol Cell Physiol; 2003 Oct; 285(4):C945-58. PubMed ID: 12958028
[TBL] [Abstract][Full Text] [Related]
26. Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists.
Sun W; Yang F; Zhang H; Yuan Q; Ling S; Wang Y; Lv P; Li Z; Luo Y; Liu D; Yin W; Shi P; Xu HE; Tian C
Cell Discov; 2023 Jun; 9(1):66. PubMed ID: 37391393
[TBL] [Abstract][Full Text] [Related]
27. Prenatal testosterone excess decreases neurokinin 3 receptor immunoreactivity within the arcuate nucleus KNDy cell population.
Ahn T; Fergani C; Coolen LM; Padmanabhan V; Lehman MN
J Neuroendocrinol; 2015 Feb; 27(2):100-10. PubMed ID: 25496429
[TBL] [Abstract][Full Text] [Related]
28. Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin.
Sarau HM; Mooney JL; Schmidt DB; Foley JJ; Buckley PT; Giardina GA; Wang DY; Lee JA; Hay DW
Mol Pharmacol; 2000 Sep; 58(3):552-9. PubMed ID: 10953048
[TBL] [Abstract][Full Text] [Related]
29. Both Estrogen and Androgen Modify the Response to Activation of Neurokinin-3 and κ-Opioid Receptors in Arcuate Kisspeptin Neurons From Male Mice.
Ruka KA; Burger LL; Moenter SM
Endocrinology; 2016 Feb; 157(2):752-63. PubMed ID: 26562263
[TBL] [Abstract][Full Text] [Related]
30. Novel pituitary actions of TAC3 gene products in fish model: receptor specificity and signal transduction for prolactin and somatolactin α regulation by neurokinin B (NKB) and NKB-related peptide in carp pituitary cells.
Hu G; He M; Ko WK; Lin C; Wong AO
Endocrinology; 2014 Sep; 155(9):3582-96. PubMed ID: 24971612
[TBL] [Abstract][Full Text] [Related]
31. Structural characterization of neurokinin-3 receptor selective peptide agonist scyliorhinin II bound to DPC micelles.
Dike A; Cowsik SM
J Biomol Struct Dyn; 2008 Feb; 25(4):395-405. PubMed ID: 18092834
[TBL] [Abstract][Full Text] [Related]
32. TACR3 mutations disrupt NK3R function through distinct mechanisms in GnRH-deficient patients.
Noel SD; Abreu AP; Xu S; Muyide T; Gianetti E; Tusset C; Carroll J; Latronico AC; Seminara SB; Carroll RS; Kaiser UB
FASEB J; 2014 Apr; 28(4):1924-37. PubMed ID: 24376026
[TBL] [Abstract][Full Text] [Related]
33. Characterization of putative tachykinin peptides in Caenorhabditis elegans.
Sakai N; Ohno H; Yoshida M; Iwamoto E; Kurogi A; Jiang D; Sato T; Miyazato M; Kojima M; Kato J; Ida T
Biochem Biophys Res Commun; 2021 Jun; 559():197-202. PubMed ID: 33945998
[TBL] [Abstract][Full Text] [Related]
34. Functional characterization of tachykinin NK1 receptors in the mouse uterus.
Patak E; Pennefather JN; Fleming A; Story ME
Br J Pharmacol; 2002 Dec; 137(8):1247-54. PubMed ID: 12466234
[TBL] [Abstract][Full Text] [Related]
35. A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial Ganglia neurons.
Myers AC; Goldie RG; Hay DW
Am J Respir Crit Care Med; 2005 Feb; 171(3):212-6. PubMed ID: 15477495
[TBL] [Abstract][Full Text] [Related]
36. Heterologous regulation of trafficking and signaling of G protein-coupled receptors: beta-arrestin-dependent interactions between neurokinin receptors.
Schmidlin F; Déry O; Bunnett NW; Grady EF
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3324-9. PubMed ID: 11880656
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, activity on NK-3 tachykinin receptor and conformational solution studies of scyliorhinin II analogs modified at position 16.
Rodziewicz-Motowidło S; Lesner A; Łegowska A; Czaplewski C; Liwo A; Rolka K; Patacchini R; Quartara L
J Pept Res; 2001 Aug; 58(2):159-72. PubMed ID: 11532075
[TBL] [Abstract][Full Text] [Related]
38. Tachykinins and tachykinin receptors in human uterus.
Patak E; Candenas ML; Pennefather JN; Ziccone S; Lilley A; Martín JD; Flores C; Mantecón AG; Story ME; Pinto FM
Br J Pharmacol; 2003 Jun; 139(3):523-32. PubMed ID: 12788812
[TBL] [Abstract][Full Text] [Related]
39. Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor.
Nederpelt I; Bleeker D; Tuijt B; IJzerman AP; Heitman LH
Biochem Pharmacol; 2016 Oct; 118():88-95. PubMed ID: 27501920
[TBL] [Abstract][Full Text] [Related]
40. Development of novel NK3 receptor antagonists with reduced environmental impact.
Yamamoto K; Okazaki S; Ohno H; Matsuda F; Ohkura S; Maeda K; Fujii N; Oishi S
Bioorg Med Chem; 2016 Aug; 24(16):3494-500. PubMed ID: 27298001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
